{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:13:47Z","timestamp":1777886027851,"version":"3.51.4"},"reference-count":54,"publisher":"Journal of the ASEAN Federation of Endocrine Societies (JAFES)","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J ASEAN Fed Endocr Soc"],"abstract":"<jats:p>Background. Individuals with diabetes mellitus (DM) show increased susceptibility to COVID-19 infection with higher risk for severe disease and mortality.\r\nObjectives. We investigated whether glycemic-related factors may affect the outcomes of patients with DM hospitalized due to COVID-19.\u00a0\r\nMethodology. This is a multicenter retrospective cohort study under the initiative of the Philippine College of Endocrinology, Diabetes, and Metabolism involving eight training hospitals in the Philippines from January 2021 to January 2022. Patients with DM hospitalized due to COVID-19 were included. Multiple binary logistic regression was done to determine whether baseline glycemic control based on glycosylated hemoglobin (HbA1c) and inpatient glycemic control based on capillary blood glucose are associated with composite poor clinical outcome of mortality and end-organ dysfunction.\r\nResults. Among 1,093 patients, 54% had HbA1c &gt;7%. Both poor baseline glycemic (AOR 1.41, p= 0.017) and poor inpatient glycemic control (AOR 2.6, p&lt;0.001) were associated with composite poor clinical outcome of mortality and end-organ dysfunction. HbA1c &gt;7% increased the odds of poor inpatient control (OR = 3.10, 95% CI: 2.32\u20134.17, p &lt; 0.001), even after adjusting for steroid use.\r\nConclusion. Poor inpatient glycemic control has greater effect on mortality and end-organ dysfunction than baseline glycemic control. However, baseline HbA1c &gt;7% is predictive of poor inpatient glycemic control. Measures to optimize glycemic control both in the long term and during hospitalization will improve clinical outcomes for DM patients with COVID-19.<\/jats:p>","DOI":"10.15605\/jafes.041.01.5089","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:21:37Z","timestamp":1777605697000},"source":"Crossref","is-referenced-by-count":0,"title":["Effect of Baseline HbA1c and Inpatient Glycemic Control on Mortality and Organ Dysfunction among Patients with Diabetes Mellitus Hospitalized for COVID-19: A Multicenter Retrospective Cohort Study"],"prefix":"10.15605","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0974-8766","authenticated-orcid":false,"given":"Mari Des","family":"San Juan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1615-9900","authenticated-orcid":false,"given":"Jennifer Lourdes","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8665-8377","authenticated-orcid":false,"given":"John Paul Martin","family":"Bagos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7913-6941","authenticated-orcid":false,"given":"Marion","family":"Sarigumba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-9334","authenticated-orcid":false,"given":"Jekrylei","family":"Cadeli\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7898-1433","authenticated-orcid":false,"given":"Ronald","family":"Chua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1285-6450","authenticated-orcid":false,"given":"Darius","family":"Enario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9789-7755","authenticated-orcid":false,"given":"Margarita Katrina Amor","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Paz-Pacheco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4351-3637","authenticated-orcid":false,"given":"Sahra May","family":"Paragas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7245-3066","authenticated-orcid":false,"given":"Erick","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Princess","family":"Kanapi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Chua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy Ceryl","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0296-4307","authenticated-orcid":false,"given":"Cecille","family":"Dela Paz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0511-046X","authenticated-orcid":false,"given":"Karla Kristine","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6244","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"85072","doi-asserted-by":"crossref","unstructured":"Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2020;14(4):395-403. https:\/\/pubmed.ncbi.nlm.nih.gov\/32334395\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7162793\/ https:\/\/doi.org\/10.1016\/j.dsx.2020.04.018","DOI":"10.1016\/j.dsx.2020.04.018"},{"key":"85073","doi-asserted-by":"crossref","unstructured":"Kumar A, Arora A, Sharma P, et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr. 2020;14(4):535-45. https:\/\/pubmed.ncbi.nlm.nih.gov\/32408118\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7200339\/ https:\/\/doi.org\/10.1016\/j.dsx.2020.04.044","DOI":"10.1016\/j.dsx.2020.04.044"},{"key":"85074","doi-asserted-by":"crossref","unstructured":"Bode B, Garrett V, Messler J, et al. Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol. 2020;14(4):813-21. https:\/\/pubmed.ncbi.nlm.nih.gov\/32389027\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7673150\/ https:\/\/doi.org\/10.1177\/1932296820924469","DOI":"10.1177\/1932296820924469"},{"key":"85075","doi-asserted-by":"crossref","unstructured":"Cariou B, Hadjadj S, Wargny M, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: The CORONADO study. Diabetologia. 2020;63(8):1500-15. https:\/\/pubmed.ncbi.nlm.nih.gov\/32472191\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7256180\/ https:\/\/doi.org\/10.1007\/s00125-020-05180-x","DOI":"10.1007\/s00125-020-05180-x"},{"key":"85076","doi-asserted-by":"crossref","unstructured":"Edrada EM, Lopez EB, Villarama JB, et al. First COVID-19 infections in the Philippines: A case report. Trop Med Health. 2020;48:21. https:\/\/pubmed.ncbi.nlm.nih.gov\/32308532\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7154063\/ https:\/\/doi.org\/10.1186\/s41182-020-00203-0","DOI":"10.1186\/s41182-020-00203-0"},{"key":"85077","doi-asserted-by":"crossref","unstructured":"Haw NJL, Uy J, Sy KTL, Abrigo MRM. Epidemiological profile and transmission dynamics of COVID-19 in the Philippines. Epidemiol Infect. 2020;148:e204. https:\/\/pubmed.ncbi.nlm.nih.gov\/32928322\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7506175\/","DOI":"10.1017\/S0950268820002137"},{"key":"85078","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1017\/S0950268820002137","DOI":"10.1017\/S0950268820002137"},{"key":"85079","unstructured":"World Health Organization. Philippines Coronavirus Disease 2019 (COVID-19) Situation Report #93. 2022. Accessed July 7, 2025. https:\/\/www.who.int\/docs\/default-source\/wpro---documents\/countries\/philippines\/emergencies\/covid-19\/who_phl_sitrep_93_covid-19.pdf"},{"key":"85080","unstructured":"National Task Force against COVID-19. National Action Plan Against COVID-19: Phase III. https:\/\/wrd.unwomen.org\/sites\/default\/files\/2023-02\/PHILIPPINES_National-Action-Plan-against-COVID19.pdf"},{"key":"85081","unstructured":"Healthcare Professionals Alliance Against COVID-19. Unified COVID-19 Algorithms version 4. https:\/\/psmid.org\/wp-content\/uploads\/2025\/10\/Unified-COVID-19-Algorithms-Version-4_Final.pdf"},{"key":"85082","doi-asserted-by":"crossref","unstructured":"Pelle MC, Zaffina I, Provenzano M, et al. COVID-19 and diabetes\u2014Two giants colliding: From pathophysiology to management. Front Endocrinol (Lausanne). 2022;13:974540. https:\/\/pubmed.ncbi.nlm.nih.gov\/36060943\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9437522\/ https:\/\/doi.org\/10.3389\/fendo.2022.974540","DOI":"10.3389\/fendo.2022.974540"},{"key":"85083","doi-asserted-by":"crossref","unstructured":"ElSayed NA, Aleppo G, Aroda VR, et al. Classification and diagnosis of diabetes: Standards of care in diabetes\u20142023. Diabetes Care. 2023;46(Suppl 1):S19-S40. https:\/\/pubmed.ncbi.nlm.nih.gov\/36507649\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9810477\/","DOI":"10.2337\/dc23-er05"},{"key":"85084","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2337\/dc23-S002","DOI":"10.2337\/dc23-S002"},{"key":"85085","doi-asserted-by":"crossref","unstructured":"Maher JM, Markey JC, Ebert-May D. The other half of the story: Effect size analysis in quantitative research. CBE Life Sci Educ. 2013;12(3):345-51. https:\/\/pubmed.ncbi.nlm.nih.gov\/24006382\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3763001\/ https:\/\/doi.org\/10.1187\/cbe.13-04-0082","DOI":"10.1187\/cbe.13-04-0082"},{"key":"85086","unstructured":"Allison PD. Measures of fit for logistic regression. 2014. Corpus ID: 13909621."},{"key":"85087","doi-asserted-by":"crossref","unstructured":"Tjur T. Coefficients of determination in logistic regression models\u2014a new proposal: The coefficient of discrimination. Am Stat. 2009. https:\/\/doi.org\/10.1198\/tast.2009.08210 Corpus ID: 121927418","DOI":"10.1198\/tast.2009.08210"},{"key":"85088","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. Glycemic goals and hypoglycemia: Standards of care in diabetes\u20142024. Diabetes Care. 2024;47(Suppl 1):S111-S125. https:\/\/pubmed.ncbi.nlm.nih.gov\/38078586\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10725808\/ https:\/\/doi.org\/10.2337\/dc24-S006","DOI":"10.2337\/dc24-S006"},{"key":"85089","doi-asserted-by":"crossref","unstructured":"Goldberg PA, Bozzo JE, Thomas PG, et al. \u201cGlucometrics\u201d\u2014assessing the quality of inpatient glucose management. Diabetes Technol Ther. 2006;8(5):560-9. https:\/\/pubmed.ncbi.nlm.nih.gov\/17037970\/ https:\/\/doi.org\/10.1089\/dia.2006.8.560","DOI":"10.1089\/dia.2006.8.560"},{"key":"85090","unstructured":"World Health Organization. The Asia-Pacific perspective: Redefining obesity and its treatment. Sydney: Health Communications Australia; 2000. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/53228dc6-9520-421b-b5a2-f826967090cb\/content"},{"key":"85091","doi-asserted-by":"crossref","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801-10. https:\/\/pubmed.ncbi.nlm.nih.gov\/26903338\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4968574\/ https:\/\/doi.org\/10.1001\/jama.2016.0287","DOI":"10.1001\/jama.2016.0287"},{"key":"85092","unstructured":"World Health Organization. Clinical management of COVID-19: Interim guidance. 2020. https:\/\/www.who.int\/publications\/i\/item\/clinical-management-of-covid-19\/"},{"key":"85093","doi-asserted-by":"crossref","unstructured":"Lin W. The association between body mass index and glycohemoglobin (HbA1c) in the US population's diabetes status. Int J Environ Res Public Health. 2024;21(5):517. https:\/\/pubmed.ncbi.nlm.nih.gov\/38791732\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC11121031\/ https:\/\/doi.org\/10.3390\/ijerph21050517","DOI":"10.3390\/ijerph21050517"},{"key":"85094","doi-asserted-by":"crossref","unstructured":"Gupta M, Gupta T, Gupta T. Physician-visit frequency and its impact on glycemic control in people with type 2 diabetes: Quantifying care acceptance parameters from retrospective electronic health record data. Cureus. 2024;16(12):e76527. https:\/\/pubmed.ncbi.nlm.nih.gov\/39877765\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC11772562\/ https:\/\/doi.org\/10.7759\/cureus.76527","DOI":"10.7759\/cureus.76527"},{"key":"85095","doi-asserted-by":"crossref","unstructured":"Xu W, Mak IL, Zhang R, et al. Optimizing the frequency of physician encounters in follow-up care for patients with type 2 diabetes mellitus: A systematic review. BMC Prim Care. 2024;25(1):41. https:\/\/pubmed.ncbi.nlm.nih.gov\/38279105\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10811944\/ https:\/\/doi.org\/10.1186\/s12875-024-02277-9","DOI":"10.1186\/s12875-024-02277-9"},{"key":"85096","doi-asserted-by":"crossref","unstructured":"Qu F, Shi Q, Wang Y, et al. Visit-to-visit glycated hemoglobin A1c variability in adults with type 2 diabetes: A systematic review and meta-analysis. Chin Med J (Engl). 2022;135(19):2294-2300. https:\/\/pubmed.ncbi.nlm.nih.gov\/35952315\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9771337\/ https:\/\/doi.org\/10.1097\/CM9.0000000000002073","DOI":"10.1097\/CM9.0000000000002073"},{"key":"85097","unstructured":"Zhu NA, Reichert S, Harris SB. Limitations of hemoglobin A1c in the management of type 2 diabetes mellitus. Can Fam Physician. 2020;66(2):112-4. https:\/\/pubmed.ncbi.nlm.nih.gov\/32060191\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7021345\/"},{"key":"85098","doi-asserted-by":"crossref","unstructured":"KDIGO Diabetes Work Group. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2022;102(5S):S1-S127. https:\/\/pubmed.ncbi.nlm.nih.gov\/36272764\/ https:\/\/doi.org\/10.1016\/j.kint.2022.06.008","DOI":"10.1016\/j.kint.2022.06.008"},{"key":"85099","doi-asserted-by":"crossref","unstructured":"Novida H, Soelistyo SA, Cahyani C, et al. Factors associated with disease severity of COVID-19 in patients with type 2 diabetes mellitus. Biomed Rep. 2022;18(1):8. https:\/\/pubmed.ncbi.nlm.nih.gov\/36570802\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9764056\/","DOI":"10.3892\/br.2022.1590"},{"key":"85100","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3892\/br.2022.1590","DOI":"10.3892\/br.2022.1590"},{"key":"85101","doi-asserted-by":"crossref","unstructured":"Floyd JS, Walker RL, Kuntz JL, et al. Association between diabetes severity and risks of COVID-19 infection and outcomes. J Gen Intern Med. 2023;38(6):1484-92. https:\/\/pubmed.ncbi.nlm.nih.gov\/36795328\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9933797\/","DOI":"10.1007\/s11606-023-08076-9"},{"key":"85102","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s11606-023-08076-9","DOI":"10.1007\/s11606-023-08076-9"},{"key":"85103","doi-asserted-by":"crossref","unstructured":"Sardu C, D\u2019Onofrio N, Balestrieri ML, et al. Hyperglycaemia on admission to hospital and COVID-19. Diabetologia. 2020;63(11):2486-7. https:\/\/pubmed.ncbi.nlm.nih.gov\/32632527\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7335920\/ https:\/\/doi.org\/10.1007\/s00125-020-05216-2","DOI":"10.1007\/s00125-020-05216-2"},{"key":"85104","doi-asserted-by":"crossref","unstructured":"Zhu L, She ZG, Cheng X, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31(6):1068-77.e3. https:\/\/pubmed.ncbi.nlm.nih.gov\/32369736\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7252168\/ https:\/\/doi.org\/10.1016\/j.cmet.2020.04.021","DOI":"10.1016\/j.cmet.2020.04.021"},{"key":"85105","doi-asserted-by":"crossref","unstructured":"Bhatti JM, Raza SA, Shahid MO, et al. Association between glycemic control and the outcome in hospitalized patients with COVID-19. Endocrine. 2022;77(2):213-20. https:\/\/pubmed.ncbi.nlm.nih.gov\/35596836\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9123611\/","DOI":"10.1007\/s12020-022-03078-9"},{"key":"85106","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s12020-022-03078-9 Liu L, Wei W, Yang K, et al. Glycemic control before admission is an important determinant of prognosis in patients with coronavirus disease 2019. J Diabetes Investig. 2021;12(6):1064-73. https:\/\/pubmed.ncbi.nlm.nih.gov\/33035409\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7675705\/ https:\/\/doi.org\/10.1111\/jdi.13431","DOI":"10.1111\/jdi.13431"},{"key":"85107","doi-asserted-by":"crossref","unstructured":"Windham S, Wilson MP, Fling C, et al. Elevated glycohemoglobin is linked to critical illness in COVID-19: A retrospective analysis. Ther Adv Infect Dis. 2021;8:20499361211027390. https:\/\/pubmed.ncbi.nlm.nih.gov\/34249357\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8239973\/ https:\/\/doi.org\/10.1177\/20499361211027390","DOI":"10.1177\/20499361211027390"},{"key":"85108","doi-asserted-by":"crossref","unstructured":"Lesniak C, Ong R, Akula MS, et al. Inpatient glycemic control and outcome of COVID-19 patients: A retrospective cohort. SAGE Open Med. 2021;9:20503121211039105. https:\/\/pubmed.ncbi.nlm.nih.gov\/34422272\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8375327\/ https:\/\/doi.org\/10.1177\/20503121211039105","DOI":"10.1177\/20503121211039105"},{"key":"85109","doi-asserted-by":"crossref","unstructured":"Wang B, Glicksberg BS, Nadkarni GN, Vashishth D. Evaluation and management of COVID-19-related severity in people with type 2 diabetes. BMJ Open Diabetes Res Care. 2021;9(1):e002299. https:\/\/pubmed.ncbi.nlm.nih.gov\/34493495\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8424422\/ https:\/\/doi.org\/10.1136\/bmjdrc-2021-002299","DOI":"10.1136\/bmjdrc-2021-002299"},{"key":"85110","doi-asserted-by":"crossref","unstructured":"Bhandari S, Rankawat G, Singh A, et al. Impact of glycemic control in diabetes mellitus on management of COVID-19 infection. Int J Diabetes Dev Ctries. 2020;40(3):340-5. https:\/\/pubmed.ncbi.nlm.nih.gov\/32905072\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7466921\/ https:\/\/doi.org\/10.1007\/s13410-020-00868-7","DOI":"10.1007\/s13410-020-00868-7"},{"key":"85111","doi-asserted-by":"crossref","unstructured":"Parthasarathy S, Chamorro-Pareja N, Kharawala A, et al. Diabetic ketoacidosis was associated with high morbidity and mortality in hospitalized patients with COVID-19 in the NYC public health system. Diabetology. 2022;3(3):36. https:\/\/doi.org\/10.3390\/diabetology3030036","DOI":"10.3390\/diabetology3030036"},{"key":"85112","doi-asserted-by":"crossref","unstructured":"Lombardi A, Agarwal S, Schechter C, Tomer Y. In-hospital hyperglycemia is associated with worse outcomes in patients admitted with COVID-19. Diabetes Care. 2022;45(11):2683-8. https:\/\/pubmed.ncbi.nlm.nih.gov\/36041197\/","DOI":"10.2337\/dc22-0708"},{"key":"85113","doi-asserted-by":"crossref","unstructured":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9679263\/ https:\/\/doi.org\/10.2337\/dc22-0708","DOI":"10.2337\/dc22-0708"},{"key":"85114","doi-asserted-by":"crossref","unstructured":"Israel A, Sch\u00e4ffer AA, Merzon E, et al. A calculator for COVID-19 severity prediction based on patient risk factors and number of vaccines received. Microorganisms. 2022;10(6):1238. https:\/\/pubmed.ncbi.nlm.nih.gov\/35744754\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9229599\/ https:\/\/doi.org\/10.3390\/microorganisms10061238","DOI":"10.3390\/microorganisms10061238"},{"key":"85115","doi-asserted-by":"crossref","unstructured":"Zhang Y, Li H, Zhang J, et al. The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single-centre, retrospective, observational study in Wuhan. Diabetes Obes Metab. 2020;22(8):1443-54. https:\/\/pubmed.ncbi.nlm.nih.gov\/32406594\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7273002\/","DOI":"10.1111\/dom.14086"},{"key":"85116","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/dom.14086","DOI":"10.1111\/dom.14086"},{"key":"85117","doi-asserted-by":"crossref","unstructured":"Parolin SAEC, Stocco RB, Lopes JCK, et al. Association between inpatient glycemic variability and COVID-19 mortality: A prospective study. Diabetol Metab Syndr. 2023;15(1):185. https:\/\/pubmed.ncbi.nlm.nih.gov\/37697407\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10494398\/ https:\/\/doi.org\/10.1186\/s13098-023-01157-z","DOI":"10.1186\/s13098-023-01157-z"},{"key":"85118","doi-asserted-by":"crossref","unstructured":"Zhang T, Wang N, Zhu L, et al. Bidirectional relationship between glycemic control and COVID-19 and perspectives of islet organoid models of SARS-CoV-2 infection. Biomedicines. 2023;11(3):856. https:\/\/pubmed.ncbi.nlm.nih.gov\/36979836\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10045433\/ https:\/\/doi.org\/10.3390\/biomedicines11030856","DOI":"10.3390\/biomedicines11030856"},{"key":"85119","doi-asserted-by":"crossref","unstructured":"Wu C-T, Lidsky PV, Xiao Y, et al. SARS-CoV-2 infects human pancreatic \u03b2 cells and elicits \u03b2 cell impairment. Cell Metab. 2021;33(8):1565-76.e5. https:\/\/pubmed.ncbi.nlm.nih.gov\/34081912\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8130512\/","DOI":"10.1016\/j.cmet.2021.05.013"},{"key":"85120","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.cmet.2021.05.013","DOI":"10.1016\/j.cmet.2021.05.013"},{"key":"85121","unstructured":"Philippine Genome Center. PGC SARS-CoV-2 Bulletin No. 6: First case of the new variant under Lineage B.1.1.7 detected in the Philippines. https:\/\/pgc.up.edu.ph\/pgc-sars-cov-2-bulletin-no-6\/"},{"key":"85122","unstructured":"The Guardian. Manila in lockdown as Delta cases soar in Philippines. Accessed July 7, 2025. https:\/\/www.theguardian.com\/world\/2021\/aug\/09\/manila-covid-lockdown-delta-cases-philippines"},{"key":"85123","doi-asserted-by":"crossref","unstructured":"Li YT, Polotan FGM, Sotelo GIS, et al. Lineage BA.2 dominated the Omicron SARS-CoV-2 epidemic wave in the Philippines. Virus Evol. 2022;8(2):veac078. https:\/\/pubmed.ncbi.nlm.nih.gov\/36090771\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9452094\/","DOI":"10.1093\/ve\/veac078"},{"key":"85124","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/ve\/veac078","DOI":"10.1093\/ve\/veac078"},{"key":"85125","unstructured":"Healthcare Professionals Alliance Against COVID-19. Unified COVID-19 Algorithms. https:\/\/psmid.org\/unified-covid-19-algorithms\/"}],"container-title":["Journal of the ASEAN Federation of Endocrine Societies"],"original-title":[],"link":[{"URL":"https:\/\/asean-endocrinejournal.org\/index.php\/JAFES\/article\/download\/5089\/5335","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/asean-endocrinejournal.org\/index.php\/JAFES\/article\/download\/5089\/5335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:22:31Z","timestamp":1777605751000},"score":1,"resource":{"primary":{"URL":"https:\/\/asean-endocrinejournal.org\/index.php\/JAFES\/article\/view\/5089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":54,"URL":"https:\/\/doi.org\/10.15605\/jafes.041.01.5089","relation":{},"ISSN":["2308-118X","0857-1074"],"issn-type":[{"value":"2308-118X","type":"electronic"},{"value":"0857-1074","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,27]]}}}